News
Annual Report and Company Brochure
Read more about Nycomed in the Company Brochure 2008 and in the Annual Report 2007. 
Where we work
Nycomed is present in over 50 countries.

Find your local Nycomed website and office and the way to our headquarters in Zurich, Switzerland.
 Soft-Relaunch Pictures

Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory diseases, inflammation diseases, pain, osteoporosis and tissue management.

Its R&D is built to be open for partnerships also beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company’s growth strategy.
 


The company employs 12,000 associates worldwide, and its products are available in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, and Latin America. While the US and Japan are commercialised through best-in-class partners, Nycomed will further strengthen its position in key Asian markets.

Headquartered in Zurich/Switzerland, the company generated in 2007 total sales of € 3.5 billion and an adjusted EBITDA of € 1.2 billion.

Disclaimer